Bobak Azamian

Bobak Azamian

Amministratore Delegato presso TARSUS PHARMACEUTICALS, INC.

Patrimonio netto: 53 M $ in data 31/05/2026

48 anni
Health Technology
Consumer Services
Finance

Profilo

Bobak Azamian was the founder of Metavention, Inc., founded in 2012, where the title held was President & Chief Medical Officer in 2018.
Dr. Azamian is the founder of Tarsus Pharmaceuticals, Inc., founded in 2017, holding the titles of Chairman, President & Chief Executive Officer since 2022.
Dr. Azamian is the founder of Vibrato Medical, Inc., founded in 2016, serving as Director.
Dr. Azamian is also the founder of Novel Therapeutics Co...
Dr. Azamian currently serves as Director at Osanni Bio, Inc. since 2022.
Former positions include Director at OCTANe, Principal at Amgen, Inc., Principal at Versant Venture Management LLC, and Senior Associate at Third Rock Ventures LLC.
Education includes a doctorate from the University of Oxford, an undergraduate degree from William Marsh Rice University, and a doctorate from Harvard Medical School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
31/03/2026 891.412 ( 2,07% ) 53 M $ 31/05/2026

Posizioni attive di Bobak Azamian

SocietàPosizioneInizio
TARSUS PHARMACEUTICALS, INC. Amministratore Delegato 01/09/2018
Fondatore 01/12/2016

Precedenti posizioni note di Bobak Azamian

SocietàPosizioneFine
Amministratore Delegato 01/01/2018
Novel Therapeutics Co.
Fondatore -
Direttore/Membro del Consiglio -
Investitore di Private Equity -
AMGEN INC. Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Bobak Azamian

Formazione di Bobak Azamian

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

2

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private11

Health Technology

Consumer Services

Consumer Services

Finance

Finance

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Novel Therapeutics Co.

  1. Mercati
  2. Insiders
  3. Bobak Azamian
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA